Fiche centre
Hôpital Lariboisière
Paris — France
Essais liés7clinical trials
VilleParislocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06159673
Essais cliniques associés
7| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| low-calorie low-protein | Myopathies | Non applicable | NCT03573739 | NUTRIREA3 — Impact of Early Low-Calorie Low-Protein Versus Standard Feeding on Outcomes of Ventilated Adults With Shock | COMPLETED |
| ACP-204 | Alzheimer | Phase 2/3 | NCT06159673 | ACP-204 in Adults With Alzheimer's Disease Psychosis | RECRUITING |
| ACP-204 | Alzheimer | Phase 3 | NCT06194799 | ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study | ENROLLING_BY_INVITATION |
| Trontinemab | Alzheimer | Phase 3 | NCT07169578 | TRONTIER 1 — A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | RECRUITING |
| Clorazepate Dipotassium | Migraine | Phase 3 | NCT04726592 | CLORMIG — Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room | TERMINATED |
| RGn600 | Alzheimer | Non applicable | NCT05926011 | LIGHT4LIFE — Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease | RECRUITING |
| RO7269162 | Alzheimer | Phase 2 | NCT06402838 | A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD) | ACTIVE_NOT_RECRUITING |